These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 8431889)
21. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. Jacobs I; Davies AP; Bridges J; Stabile I; Fay T; Lower A; Grudzinskas JG; Oram D BMJ; 1993 Apr; 306(6884):1030-4. PubMed ID: 8490497 [TBL] [Abstract][Full Text] [Related]
22. Ultrasound screening for the early detection of ovarian cancer. DePriest PD; DeSimone CP J Clin Oncol; 2003 May; 21(10 Suppl):194s-199s. PubMed ID: 12743134 [TBL] [Abstract][Full Text] [Related]
23. Normal Risk Ovarian Screening Study: 21-Year Update. Han CY; Lu KH; Corrigan G; Perez A; Kohring SD; Celestino J; Bedi D; Bedia E; Bevers T; Boruta D; Carlson M; Holman L; Leeds L; Mathews C; McCann G; Moore RG; Schlumbrecht M; Slomovitz B; Tobias D; Williams-Brown Y; Bevers MW; Liu J; Gornet TG; Handy BC; Lu Z; Bedia JS; Skates SJ; Bast RC J Clin Oncol; 2024 Apr; 42(10):1102-1109. PubMed ID: 38194613 [TBL] [Abstract][Full Text] [Related]
24. Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare. Bast RC Trans Am Clin Climatol Assoc; 2004; 115():233-47; discussion 247-8. PubMed ID: 17060970 [TBL] [Abstract][Full Text] [Related]
25. Status of tumor markers in ovarian cancer screening. Bast RC J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135 [TBL] [Abstract][Full Text] [Related]
26. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening. Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925 [TBL] [Abstract][Full Text] [Related]
27. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496 [TBL] [Abstract][Full Text] [Related]
28. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements. Czekierdowski A Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913 [TBL] [Abstract][Full Text] [Related]
29. [Early detection and preoperative diagnosis of ovarian carcinoma]. Kainz C Wien Med Wochenschr; 1996; 146(1-2):2-7. PubMed ID: 8835487 [TBL] [Abstract][Full Text] [Related]
30. Screening for ovarian cancer. Carlson KJ; Skates SJ; Singer DE Ann Intern Med; 1994 Jul; 121(2):124-32. PubMed ID: 8017726 [TBL] [Abstract][Full Text] [Related]
31. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205 [TBL] [Abstract][Full Text] [Related]
32. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer. Hata K; Hata T; Manabe A; Sugimura K; Kitao M Obstet Gynecol; 1992 Dec; 80(6):922-6. PubMed ID: 1448260 [TBL] [Abstract][Full Text] [Related]
33. Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer. Fukuyama A; Yokoyama Y; Wada J; Hashimoto T; Oda T; Sato S; Mizunuma H Eur J Gynaecol Oncol; 2009; 30(2):208-10. PubMed ID: 19480258 [TBL] [Abstract][Full Text] [Related]
34. Ovarian cancer screening. Sparks JM; Varner RE Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097 [TBL] [Abstract][Full Text] [Related]
35. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3. Jacobs IJ; Oram DH; Bast RC Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694 [TBL] [Abstract][Full Text] [Related]
36. Screening for early ovarian cancer. Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556 [TBL] [Abstract][Full Text] [Related]
37. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Kramer BS; Gohagan J; Prorok PC; Smart C Cancer; 1993 Jan; 71(2 Suppl):589-93. PubMed ID: 8420681 [TBL] [Abstract][Full Text] [Related]
38. [Is ultrasound screening for ovarian cancer possible in 1998?]. Descamps P; Fondrinier E; Biquard F; Binelli C; Lepinard C; Loisel D; Crvencowitcz G; Platt LD; Karlan BY J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):476-81. PubMed ID: 9791573 [TBL] [Abstract][Full Text] [Related]
39. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system. Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018 [TBL] [Abstract][Full Text] [Related]
40. The efficacy of a sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation. DePriest PD; Varner E; Powell J; Fried A; Puls L; Higgins R; Shenson D; Kryscio R; Hunter JE; Andrews SJ Gynecol Oncol; 1994 Nov; 55(2):174-8. PubMed ID: 7959280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]